Michelle Petri, MD MPH

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Novaratis
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Owkin
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    10/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Precision Biosciences
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    06/30/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Regeneron Pharmaceuticals
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    11/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Santa Ana Bio
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    03/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Seismic Theuapeutics
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    10/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Senti Biosciences
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    04/01/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Steritas
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    05/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Takeda
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    12/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Tenet Medicine Inc
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    11/30/2024

Pages

Return to 2026 Florida Society of Rheumatology Annual Meeting